Point72 Asset Management Reports 0.2% Stake in AnaptysBio, Inc. (ANAB)

Point72 Asset Management, L.P., along with Point72 Capital Advisors, Inc. and Steven A. Cohen, filed a Schedule 13G/A on May 15, 2026, regarding their holdings in AnaptysBio, Inc. (ANAB). The filing indicates that as of March 31, 2026, the reporting persons beneficially own 55,303 shares of common stock, representing 0.2% of the class. This reflects an increase from a previous 0.0% position. Steven A. Cohen controls both Point72 Asset Management and Point72 Capital Advisors, which maintain investment and voting power over the shares held by an investment fund managed by Point72 Asset Management. The reporting persons have certified that the securities were not acquired for the purpose of changing or influencing the control of the issuer. The filing was submitted as an amendment to a previous Schedule 13G, confirming that the group's aggregate ownership has remained below the 5% threshold typically requiring more detailed disclosure.